- Home
- GLBS vs CGTX Comparison
GLBS vs CGTX Comparison
Compare GLBS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- CGTX
- Stock Information
- Founded
- GLBS 2006
- CGTX 2007
- Country
- GLBS Greece
- CGTX United States
- Employees
- GLBS N/A
- CGTX N/A
- Industry
- GLBS Marine Transportation
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- GLBS Consumer Discretionary
- CGTX Health Care
- Exchange
- GLBS Nasdaq
- CGTX Nasdaq
- Market Cap
- GLBS 28.6M
- CGTX 30.0M
- IPO Year
- GLBS 2007
- CGTX 2021
- Fundamental
- Price
- GLBS $1.33
- CGTX $0.58
- Analyst Decision
- GLBS
- CGTX Strong Buy
- Analyst Count
- GLBS 0
- CGTX 6
- Target Price
- GLBS N/A
- CGTX $8.30
- AVG Volume (30 Days)
- GLBS 31.4K
- CGTX 809.4K
- Earning Date
- GLBS 03-14-2025
- CGTX 03-25-2025
- Dividend Yield
- GLBS N/A
- CGTX N/A
- EPS Growth
- GLBS 61.29
- CGTX N/A
- EPS
- GLBS 0.14
- CGTX N/A
- Revenue
- GLBS $33,289,000.00
- CGTX N/A
- Revenue This Year
- GLBS $15.39
- CGTX N/A
- Revenue Next Year
- GLBS $43.34
- CGTX N/A
- P/E Ratio
- GLBS $9.78
- CGTX N/A
- Revenue Growth
- GLBS 2.74
- CGTX N/A
- 52 Week Low
- GLBS $1.06
- CGTX $0.34
- 52 Week High
- GLBS $2.40
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- GLBS 51.24
- CGTX 40.43
- Support Level
- GLBS $1.20
- CGTX $0.57
- Resistance Level
- GLBS $1.38
- CGTX $0.65
- Average True Range (ATR)
- GLBS 0.08
- CGTX 0.05
- MACD
- GLBS -0.00
- CGTX -0.01
- Stochastic Oscillator
- GLBS 58.61
- CGTX 9.46
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.